Echoviruses and Coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 340-343

  Spiller, O Brad ^a   Goodfellow, Ian G ^b   Evans, David J ^b   Almond, Jeffrey W ^c   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR;

ANIMAL CELL; ARTICLE; COMPLEMENT INHIBITION; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; ECHO VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RECEPTOR BINDING; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; ANTIGENS, CD55; COMPLEMENT ACTIVATION; ENTEROVIRUS B, HUMAN; HEMAGGLUTINATION TESTS; HUMANS; MICE; RATS; RECEPTORS, VIRUS; SPECIES SPECIFICITY;

EID: 0033978073     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315210     Document Type: Article

References (15)

1. 1. Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 1998; 79:707-13.
2. 2. Bergelson JM, Chan M, Solomon KR, St. John NF, Lin H, Finberg RW. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 1994; 91:6245-9.
3. 3. Nicholson-Weller A, Wang CE. Structure and function of decay accelerating factor CD55. J Lab Clin Med 1994; 123:485-91.
4. 4. Shafren DR, Dorahy DJ, Ingram RA, Burns GF, Barry RD. Coxsackie A21 binds to decay-accelerating factor but requires intercellular adhesion molecule I for cell entry. J Virol 1997; 71:4736-43.
5. 5. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. Coxsackieviruses B1, B3, and B5 use decay-accelerating factor as a receptor for cell attachment. J Virol 1995; 69:3873-7.
6. 6. Vasilenko S, Atsev S. Experimental infection of mice with ECHO-6 virus. Acta Virol 1965; 9:541-5.
7. 7. Zimmermann H, Eggers HJ, Nelsen-Salz B. Cell attachment and mouse virulence of echovirus 9 correlate with an RGD motif in the capsid protein VP1. Virology 1997; 233:149-56.
8. 8. Roberts GBS, Boyd JF. The histopathology of enterovirus infections of newborn mice. J Infect 1987; 15:45-56.
9. 9. Danes L, Jaresova I, Lim D, Jelinek F. Elimination of some enteroviruses in the excrements of experimentally infected rats (Rattus norvegicus) and gulls (Larus ridibundus. J Hyg Epidemiol Microbiol Immunol 1984; 28: 309-18.
10. 10. Spicer AP, Seldin MF, Gendler SJ. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J Immunol 1995; 155:3079-91.
11. 11. Hinchliffe SJ, Spiller OB, Morgan BP. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55). J Immunol 1998; 161:5695-703.
12. 12. Spiller OB, Harris CL, Morgan BP. Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells. J Immunol Methods 1999; 224:51-60.
13. 13. Clarkson NA, Kaufman R, Lublin DM, et al. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J Virol 1995;69: 5497-501.
14. 14. Coyne KE, Hall SE, Thompson ES, et al. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 1992; 149:2906-13.
15. 15. Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for Coxsackie B viruses and adenoviruses. J Virol 1998; 72:415-9.